These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen. Takayasu R; Hasumi K; Shinohara C; Endo A FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095 [TBL] [Abstract][Full Text] [Related]
3. Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators. Hasumi K; Hasegawa K; Kitano Y J Antibiot (Tokyo); 2007 Jul; 60(7):463-8. PubMed ID: 17721006 [TBL] [Abstract][Full Text] [Related]
4. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. Falcone DJ; Khan KM; Layne T; Fernandes L J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061 [TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. Kassam G; Kwon M; Yoon CS; Graham KS; Young MK; Gluck S; Waisman DM J Biol Chem; 2001 Mar; 276(12):8924-33. PubMed ID: 11114303 [TBL] [Abstract][Full Text] [Related]
6. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. Sharma MR; Rothman V; Tuszynski GP; Sharma MC Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891 [TBL] [Abstract][Full Text] [Related]
7. SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a D-amino acid moiety. Hu W; Kitano Y; Hasumi K J Antibiot (Tokyo); 2003 Oct; 56(10):832-7. PubMed ID: 14700276 [TBL] [Abstract][Full Text] [Related]
9. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains. Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759 [TBL] [Abstract][Full Text] [Related]
10. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108 [TBL] [Abstract][Full Text] [Related]
11. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116 [TBL] [Abstract][Full Text] [Related]
12. Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis. Hasumi K; Ohyama S; Kohyama T; Ohsaki Y; Takayasu R; Endo A J Antibiot (Tokyo); 1998 Dec; 51(12):1059-68. PubMed ID: 10048563 [TBL] [Abstract][Full Text] [Related]
13. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis. Hatziapostolou M; Katsoris P; Papadimitriou E Eur J Pharmacol; 2003 Jan; 460(1):1-8. PubMed ID: 12535853 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system. Aisina RB; Mukhametova LI; Gulin DA; Levashov MY; Prisyazhnaya NV; Gershkovich KB; Varfolomeyev SD Biochemistry (Mosc); 2009 Oct; 74(10):1104-13. PubMed ID: 19916923 [TBL] [Abstract][Full Text] [Related]
15. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor. Kost C; Benner K; Stockmann A; Linder D; Preissner KT Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645 [TBL] [Abstract][Full Text] [Related]
16. Regulation of nonproteolytic active site formation in plasminogen. Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171 [TBL] [Abstract][Full Text] [Related]
17. Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure. Hu W; Ohyama S; Hasumi K J Antibiot (Tokyo); 2000 Mar; 53(3):241-7. PubMed ID: 10819294 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393 [TBL] [Abstract][Full Text] [Related]